High Quality Reagents


7 06, 2021

Immunity EpitoGen® COVID-19 ELISA Test

2021-06-07T10:47:57+00:00June 7th, 2021|News|

Immune memory, from either infection or immunization, is the source of long-term protective immunity. Antibodies are a key component of immune memory that can provide protection. The spike protein is the focus of most COVID-19 vaccines. Antibody responses to the spike protein and other viral proteins can [...]

17 05, 2021

EpitoGen Universal SARS-CoV-2 Assay

2021-05-17T15:44:33+00:00May 17th, 2021|News|

Universal EpitoGen® SARS-CoV-2 ELISA assay At a population level, the humoral response to SARS-CoV-2 is heterogeneous. In the course of our development of EpitoGen SARS-CoV-2 assays we observed that significant numbers of samples were only reactive for either the Spike or Nucleocapsid antigen alone. Therefore, traditional [...]

12 05, 2021

The first AI-EpitoGen COVID Antibody Assays

2021-05-12T11:01:23+00:00May 12th, 2021|News|

EpitoGen Technology and AiBiologics machine learning software (EpitopePredikt) were employed to develop a set of unique, highly sensitive SARS-Cov-2 ELISA assays. EpitopePredikt was used to scan SARS-CoV-2 antigen and identify immunodominant epitopes. The epitopes were then expressed in combination using EpitoGen Technology and validated for detection of [...]

11 05, 2021

EpitoGen Technology News

2021-05-11T10:55:29+00:00May 11th, 2021|News|

EpitoGen Technology is a novel epitope/peptide expression platform. The epitope antigen (Epitogen) is fused in the middle of an inert scaffold protein and displayed on the top of the scaffold ideally suited to a number of antigen/antibody-based assays such as ELISA and lateral flow. The technology was [...]

11 05, 2020

VAL to use proprietary AI and recombinant technologies to fight Covid-19

2020-05-11T15:16:43+00:00May 11th, 2020|News|

Vertebrate Antibodies will utilise its proprietary AI and recombinant technologies to tackle Covid-19Vertebrate Antibodies Ltd (VAL) is joining forces with leading scientists and clinicians from University of Aberdeen and NHS Grampian.Existing tests can be unreliable and are not suited to rapid and mass deployment. This project, funded by [...]

4 10, 2019

VAL Welcomes the New Director of Commercialisation

2019-10-04T14:00:20+00:00October 4th, 2019|News|

4th October 2019 VAL is pleased to confirm the appointment of Richard Atkins as Director of Commercialisation. He will lead the marketing and business development of VAL’s projects. About Richard Atkins For over 30 years Richard has become very commercially driven with significant strategic, communication and growth [...]

2 10, 2019

VAL Welcomes the New Director of Biologicals

2019-10-02T13:16:39+00:00October 2nd, 2019|News|

1st October 2019 VAL is pleased to confirm the appointment of Dr Tiehui Wang as Director of Biologicals. He will be the head of the Recombinat Division and generate active proteins for research and animal health. About Dr Tiehui Wang Dr Tiehui Wang is a leading immunologist [...]

25 09, 2019

Recent Publications from Vertebrate Antibodies Ltd (VAL).

2019-09-25T09:42:57+00:00September 25th, 2019|News|

The Journal of Pathology An abstract of the work presented at the Leeds Pathology Conference (2-4 July, 2019) has now been published in The Journal of Pathology, Volume 249 (Issue S1) Page S56. The supplement can be accessed through Wiley Online Library( WOL) View the abstract here. [...]

19 07, 2019

June 19th 2019 – Scottish Fish Immunology Research Centre Presentation

2019-07-26T09:25:26+00:00July 19th, 2019|News|

Scottish Fish Immunology Research Centre Presentation Yehfang Hu (Scottish Fish Immunology Research Centre, University of Aberdeen) attended the International Conference on Fish and Shellfish Immunology in Gran Canaria, Spain. Yehfang Hu gave a presentation entitled: Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus [...]

17 07, 2019

Leeds Pathology 2019 Conference (2-4 July | Harrogate, UK)

2019-07-17T11:21:19+00:00July 17th, 2019|News|

Leeds Pathology 2019 Conference (2-4 July | Harrogate, UK) At the Leeds Pathology 2019 Conference, Dr Abdo Alnabulsi (KTP Associate Vertebrate Antibodies Ltd, University of Aberdeen) presented a poster with the title: A Prognostic Signature of Brown Fat-Associated Proteins in Colorectal Cancer. Click here for more [...]

Go to Top